Free Trial

Verastem (VSTM) News Today

Verastem logo
$8.31 +0.83 (+11.10%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$8.24 -0.07 (-0.78%)
As of 05/23/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VSTM Latest News

Verastem, Inc. stock logo
Soleus Capital Management L.P. Reduces Stock Position in Verastem, Inc. (NASDAQ:VSTM)
Soleus Capital Management L.P. cut its stake in Verastem, Inc. (NASDAQ:VSTM - Free Report) by 22.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,184,026 shares of the biopharmaceutical company's stock after selling 643,
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Shares Sold by Stonepine Capital Management LLC
Stonepine Capital Management LLC lowered its position in Verastem, Inc. (NASDAQ:VSTM - Free Report) by 33.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 870,000 shares of the biopharmaceutical company's stock after selling 440,287 shares duri
Verastem, Inc. stock logo
Schonfeld Strategic Advisors LLC Takes $187,000 Position in Verastem, Inc. (NASDAQ:VSTM)
Schonfeld Strategic Advisors LLC acquired a new position in Verastem, Inc. (NASDAQ:VSTM - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 36,180 shares of the biopharmaceutical company's stock, valued at approximately $187,000.
Verastem, Inc. stock logo
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 177,855 Shares of Verastem, Inc. (NASDAQ:VSTM)
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Verastem, Inc. (NASDAQ:VSTM - Free Report) by 41.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 608,524 sh
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Given New $14.00 Price Target at HC Wainwright
HC Wainwright raised their price objective on shares of Verastem from $10.00 to $14.00 and gave the company a "buy" rating in a research note on Friday.
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Given Consensus Rating of "Buy" by Brokerages
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) has been given a consensus recommendation of "Buy" by the ten research firms that are presently covering the company, Marketbeat Ratings reports. Ten research analysts have rated the stock with a buy recommendation. The average 12 month price target a
Verastem, Inc. stock logo
Balyasny Asset Management L.P. Makes New $20.40 Million Investment in Verastem, Inc. (NASDAQ:VSTM)
Balyasny Asset Management L.P. purchased a new stake in shares of Verastem, Inc. (NASDAQ:VSTM - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,945,927 shares of the biopharmaceutical compan
Verastem, Inc. stock logo
Susquehanna Fundamental Investments LLC Buys New Shares in Verastem, Inc. (NASDAQ:VSTM)
Susquehanna Fundamental Investments LLC purchased a new position in shares of Verastem, Inc. (NASDAQ:VSTM - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 63,411 shares of
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Holdings Boosted by BVF Inc. IL
BVF Inc. IL grew its holdings in Verastem, Inc. (NASDAQ:VSTM - Free Report) by 24.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,100,468 shares of the biopharmaceutical company's stock after p
Verastem, Inc. stock logo
B. Riley Has Pessimistic Outlook of Verastem Q2 Earnings
Verastem, Inc. (NASDAQ:VSTM - Free Report) - Analysts at B. Riley dropped their Q2 2025 earnings estimates for Verastem in a report issued on Monday, April 28th. B. Riley analyst K. Patel now expects that the biopharmaceutical company will post earnings of ($0.56) per share for the quarter, down
Verastem, Inc. stock logo
Verastem (VSTM) to Release Earnings on Thursday
Verastem (NASDAQ:VSTM) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-verastem-inc-stock/)
Verastem, Inc. stock logo
B. Riley Has Optimistic Outlook of Verastem FY2029 Earnings
Verastem, Inc. (NASDAQ:VSTM - Free Report) - Equities research analysts at B. Riley increased their FY2029 EPS estimates for Verastem in a note issued to investors on Monday, April 28th. B. Riley analyst K. Patel now anticipates that the biopharmaceutical company will post earnings per share of $
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Shares Bought by Geode Capital Management LLC
Geode Capital Management LLC increased its stake in Verastem, Inc. (NASDAQ:VSTM - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 948,790 shares of the biopharmaceutical company's stock after buying a
Verastem, Inc. stock logo
Marshall Wace LLP Invests $4.10 Million in Verastem, Inc. (NASDAQ:VSTM)
Marshall Wace LLP acquired a new stake in shares of Verastem, Inc. (NASDAQ:VSTM - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 793,641 shares of the biopharmaceutical company's stock, valued at approximately $
Verastem Oncology rises on $75M private placement
Verastem announces U.S. IND clearance of VS-7375
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Shares Sold by Walleye Capital LLC
Walleye Capital LLC cut its stake in shares of Verastem, Inc. (NASDAQ:VSTM - Free Report) by 35.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 139,281 shares of the biopharmaceutical company's stock after selling 76,84
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Rating Lowered to Sell at StockNews.com
StockNews.com downgraded Verastem from a "hold" rating to a "sell" rating in a report on Friday.
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Position Trimmed by Kennedy Capital Management LLC
Kennedy Capital Management LLC lowered its stake in Verastem, Inc. (NASDAQ:VSTM - Free Report) by 89.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 63,050 shares of the biopharmaceutical company's stock after selling 553,720 s
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Given Consensus Recommendation of "Buy" by Analysts
Shares of Verastem, Inc. (NASDAQ:VSTM - Get Free Report) have earned an average recommendation of "Buy" from the ten analysts that are covering the company, MarketBeat reports. Ten research analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that
Verastem, Inc. stock logo
Mizuho Lowers Verastem (NASDAQ:VSTM) Price Target to $8.00
Mizuho lowered their price objective on Verastem from $9.00 to $8.00 and set an "outperform" rating for the company in a research report on Wednesday.
Verastem initiated with a Buy at Jefferies
Get Verastem News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter.

VSTM Media Mentions By Week

VSTM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VSTM
News Sentiment

0.36

0.73

Average
Medical
News Sentiment

VSTM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VSTM Articles
This Week

10

4

VSTM Articles
Average Week

Get Verastem News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VSTM) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners